ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,188Medicare Part D Prescriptions Filled, Including Refills

Rank: 118 out of 944

$670K Total Retail Price of All Prescriptions

Rank: 81 out of 944

503 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
20% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 503 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

12% of this provider’s 503 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,241 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
LEVOTHYROXINE SODIUM 621 570 1 2
LISINOPRIL 468 430 2 3
AMLODIPINE BESYLATE 455 430 3 5
ATORVASTATIN CALCIUM 448 441 4 13
SIMVASTATIN 401 359 5 1
WARFARIN SODIUM 322 311 6 7
FUROSEMIDE 278 258 7 6
OMEPRAZOLE 262 249 8 4
ZOLPIDEM TARTRATE 250 242 9 25
HYDROCODONE-ACETAMINOPHEN 197 194 S3 10 10
DIOVAN 180 153 11 38
LOSARTAN POTASSIUM 177 176 12 16
PRAVASTATIN SODIUM 169 162 13 17
POTASSIUM CHLORIDE 166 147 14 15
HYDROCHLOROTHIAZIDE 158 155 15 9
METOPROLOL SUCCINATE 158 150 15 14
METOPROLOL TARTRATE 145 145 17 8
NAMENDA 129 129 18 37
SERTRALINE HCL 125 110 19 23
DONEPEZIL HCL 124 124 20 24
ALLOPURINOL 122 117 21 22
LIPITOR 113 103 22 91
ATENOLOL 112 106 23 11
ESCITALOPRAM OXALATE 109 109 24 98
TAMSULOSIN HCL 103 103 25 27
ALENDRONATE SODIUM 96 84 26 20
PANTOPRAZOLE SODIUM 94 92 27 34
TRIAMTERENE-HCTZ 93 77 28 33
CRESTOR 81 70 29 28
METFORMIN HCL 80 74 30 12
GABAPENTIN 80 79 30 18
PREDNISONE 77 76 32 32
CLOPIDOGREL 75 75 33 36
AZITHROMYCIN 72 60 34 70
POLYETHYLENE GLYCOL 3350 67 65 35 41
LOSARTAN-HYDROCHLOROTHIAZIDE 67 65 35 54
CLONIDINE HCL 66 58 37 67
CIPROFLOXACIN HCL 66 60 37 90
SYNTHROID 64 57 39 82
CITALOPRAM HBR 64 64 39 19
FINASTERIDE 60 56 41 83
GLIMEPIRIDE 59 59 42 47
ZETIA 59 47 42 59
PLAVIX 56 56 44 55
SPIRONOLACTONE 55 48 45 44
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 51 46 141
LANTUS SOLOSTAR 52 45 47 61
ENALAPRIL MALEATE 52 52 47 43
NEXIUM 51 28 49 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.